1.34
10.67%
-0.16
Reviva Pharmaceuticals Holdings Inc (RVPH) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
17.64%
7.9221
|
9.6193 | 11.56 | 11.34 | 6.9847 |
Interest Income/Expense |
0.00349
|
- | 0.0059 | 0.0128 | 0.00766 |
Operating Income/Loss |
17.64%
-7.9221
|
-9.6193 | -11.56 | -11.34 | -6.9847 |
Nonoperating Income/Loss |
91.10%
0.4959
|
0.2595 | 0.2301 | -0.3659 | 0.136 |
Income/Loss From Continuing Operations Before Tax |
23.67%
-7.4262
|
-9.729 | -10.48 | -12.44 | -6.5996 |
Income Tax Expense/Benefit |
261.41%
0.0074
|
-0.00458 | 0.0121 | 0.00644 | 0.00298 |
Income/Loss From Continuing Operations After Tax |
20.54%
-7.4336
|
-9.3553 | -11.35 | -11.71 | -6.8517 |
Net Income/Loss
|
20.54%
-7.4336
|
-9.3553 | -11.35 | -11.71 | -6.8517 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,822%
29.89
|
1.0228 | 24.03 | 22.43 | 21.83 |
Basic Earnings Per Share |
24.24%
-0.25
|
-0.33 | -0.48 | -0.52 | -0.31 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):